Key Financial Data Of Group

Daito Pharmaceutical Co., Ltd. - Filing #7719908

Concept 2018-06-01 to
2018-08-31
As at
2018-08-31
As at
2018-05-31
2017-06-01 to
2018-05-31
As at
2017-08-31
2017-06-01 to
2017-08-31
Key financial data of group
Business results of group
Net sales
9,739,969,000 JPY
39,875,983,000 JPY
9,681,572,000 JPY
Ordinary profit (loss)
1,141,496,000 JPY
4,244,028,000 JPY
973,568,000 JPY
Profit (loss) attributable to owners of parent
779,860,000 JPY
3,041,941,000 JPY
673,298,000 JPY
Comprehensive income
795,276,000 JPY
3,095,669,000 JPY
722,928,000 JPY
Net assets
29,065,398,000 JPY
28,495,554,000 JPY
26,311,121,000 JPY
Total assets
47,439,379,000 JPY
46,898,563,000 JPY
46,257,689,000 JPY
Basic earnings (loss) per share
62.32
243.08
53.80
Diluted earnings per share
Equity-to-asset ratio
0.604 xbrli:pure
0.598 xbrli:pure
0.559 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.